109
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

, , , &
Pages 199-209 | Published online: 07 Dec 2017

References

  • National Comprehensive Cancer Network (NCCN)NCCN Clinical Practice Guidelines: Cancer- and Chemotherapy-Induced Anemia. Version 2.2017NCCN2017 Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/anemia.pdfAccessed October 8, 2017
  • KnightKWadeSBalducciLPrevalence and outcomes of anemia in cancer: a systematic review of the literatureAm J Med2004116Suppl 7A11S26S
  • SchwartzRNAnemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocolsAm J Health Syst Pharm2007643 Suppl 2S5S13
  • SteensmaDPIs anemia of cancer different from chemotherapy-induced anemia?J Clin Oncol20082671022102418227523
  • WilsonJYaoGLRafteryJA systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatmentHealth Technol Assess200711131202iiiiv
  • PerazellaMAOnco-nephrology: renal oxicities of chemotherapeutic agentsClin J Am Soc Nephrol20127101713172122879440
  • WoodPAHrusheskyJMCisplatin-associated anemia: an erythropoietin deficiency syndromeJ Clin Invest1995954165016597706473
  • BarniSCabidduMGuarneriPLonatiVPetrelliFThe risk for anemia with targeted therapies for solid tumorsOncologist201217571572422531357
  • Gafter-GviliARozen-ZviBVidalLLeiboviciLVansteenkisteJGafterUShpilbergOIntravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trialsActa Oncol2013521182922877242
  • RosnerMHAuerbachMFerumoxytol for the treatment of iron deficiencyExpert Rev Hematol20114439940621801130
  • JahnMRAndreasenHBFüttererSA comparative study of the physiochemical properties of iron isomaltoside 100 (Monofer), a new intravenous iron preparation and its clinical implicationsEur J Pharm Biopharm201178348804491
  • PaiABGarbaAOFerumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?J Blood Med20123778522973119
  • Feraheme (ferumoxytol) injection: US [prescribing information]Waltham, MAAMAG Pharmaceuticals, Inc.2015
  • HetzelDStraussWBernardKLiZUrbonieneAAllenLFA phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyAm J Hematol201489664665024639149
  • Vadhan-RajSStraussWFordDBernardKBocciaRLiJAllenLFEfficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral ironAm J Hematol201489171223983177
  • HedenusMBirgegardGThe role of iron supplementation during epoietin treatment for cancer-related anemiaMed Oncol200926110511518473194
  • BennettCLSilverSMDjulbegovicBVenous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemiaJAMA2008299891492418314434
  • HenryDHDahlNVAuerbachMAThrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV ironAm J Hematol201287330831022262486
  • HenryDHDahlVAuerbachMTchekmedyianSLaufmanLRIntravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapyOncologist200712223124217296819
  • AuerbachMBallardHTroutJRIntravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trialJ Clin Oncol20042271301130715051778
  • KimYTKimSWYoonBSEffect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapyGynecol Oncol2007105119920417234260
  • DangsuwanPManchanaTBlood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapyGynecol Oncol2010116352252520051288
  • BirgegårdGHenryDGlaspyJChopraRThomsenLLAuerbachMA randomized noninferiority trial of intravenous iron isomaltoside versus oral iron sulfate in patients with nonmyeloid malignancies and anemia receiving chemotherapy: The PROFOUND TrialPharmacotherapy201636440241426927900